Keyphrases
Hormone Concentration
100%
End-stage Renal Disease
100%
Intact Parathyroid Hormone (iPTH)
100%
Targeted Clinical Trials
100%
Clinical Outcomes
100%
Clinical Trials
25%
Secondary Hyperparathyroidism
25%
Cardiovascular Mortality
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Hypertension
12%
Cardiovascular Disease
12%
Heart Disease
12%
Cardiovascular Risk
12%
Serum Concentration
12%
Bone Health
12%
Comorbid Conditions
12%
Malnutrition
12%
Substantial Change
12%
Confounding
12%
End-stage Renal Disease Patients
12%
Fracture Rate
12%
Skeletal Fractures
12%
Take-all
12%
Balanced Group
12%
Volume Excess
12%
Medicine and Dentistry
Clinical Trial
100%
End Stage Renal Disease
100%
Parathyroid Hormone
100%
Secondary Hyperparathyroidism
25%
Disease
12%
Cardiovascular Risk
12%
Cardiovascular Disease
12%
Heart Disease
12%
Diabetes Mellitus
12%
Cardiovascular Mortality
12%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
End Stage Renal Disease
100%
Parathyroid Hormone
100%
Secondary Hyperparathyroidism
25%
Heart Disease
12%
Cardiovascular Risk
12%
Cardiovascular Mortality
12%
Disease
12%
Diabetes Mellitus
12%
Cardiovascular Disease
12%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Parathyroid Hormone Blood Level
100%
Parathyroid Hormone
33%
Blood Level
16%
Immunology and Microbiology
Parathyroid Hormone Blood Level
100%
Blood Level
16%
Neuroscience
Parathyroid Hormone
100%
Diabetes Mellitus
12%